Tiffany Eul Davis Inglis, Chief Medical Officer at SERA PROGNOSTICS, INC. (SERA), sold 362 shares at $2.01 ($728) on 2026-06-11, disclosed to the SEC on 2026-06-15.
Open-market sale of $728 SERA by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |